And it is most surprising. A new editorial states:
“In fact, we don’t know if the vaccines are safe and effective,” Allyssia Finley wrote in a WSJ editorial. “The rushed FDA action was based on extremely weak evidence. It’s one thing to show regulatory flexibility during an emergency. But for children, Covid isn’t an emergency. The FDA bent its standards to an unusual degree and brushed aside troubling evidence that warrants more investigation.”
…
“More troubling, vaccinated toddlers in Pfizer’s trial were more likely to get severely ill with Covid than those who received a placebo,” WSJ notes. “Pfizer claimed most severe cases weren’t ‘clinically significant,’ whatever that means, but this was all the more reason that the FDA should have required a longer follow-up before authorizing the vaccine.”
It’s about time the press started doing their job. This is only an editorial, but it’s the first time that the WSJ has done anything but cheer for the gene therapy team.
Leave a Reply